More articles from Airway pharmacology and treatment

Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted
Huijuan Hao, Wuping Bao, Yishu Xue, Yan Zhou, Zhixuan Huang, Dongning Yin, Yingying Zhang, Pengyu Zhang, Chengjian Lv, Lei Han, Xin Zhou, Junfeng Yin, Min Zhang

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3531; DOI: 10.1183/13993003.congress-2021.PA3531
Change from MDI to DPI in asthma: effects on climate emissions and disease control
Ashley Woodcock, Jamie Rees, David Leather, Lucy Frith, Magnus Lofdahl, Alison Moore, Martin Hedberg, Christer Janson

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3400; DOI: 10.1183/13993003.congress-2021.PA3400
Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) in ex-smoker and never smoker patients with inadequately controlled asthma: Post hoc analysis of IRIDIUM study
Huib A.M. Kerstjens, Richard Van Zyl-Smit, Kenneth Chapman, Jorge Maspero, Motoi Hosoe, Ana-Maria Tanase, David Lawrence, Abhijit Pethe, Xu Shu, Karen Mezzi, Peter D'Andrea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3387; DOI: 10.1183/13993003.congress-2021.PA3387
Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
Charles Pilette, Giorgio Walter Canonica, Rekha Chaudhuri, F. Eun-Hyung Lee, Jason Kihyuk Lee, Carlos Almonacid Sanchez, Rafael Alfonso-Cristancho, Rupert Jakes, Aoife Maxwell, Robert Price, Peter Howarth

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3539; DOI: 10.1183/13993003.congress-2021.PA3539
Triple combination therapy in severe asthma: overview from the Italian Registry Severe Asthma (IRSA)
Claudio Micheletto, Maria Beatrice Bilò, Leonardo Antonicelli, Fausto De Michele, Antonino Musarra, Adriano Vaghi

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3521; DOI: 10.1183/13993003.congress-2021.PA3521
Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study
Konstantinos Kostikas, Huib A. M. Kerstjens, Jorge F. Maspero, Kenneth R. Chapman, Richard N. Van Zyl-Smit, Motoi Hosoe, Ana-Maria Tanase, Abhijit Pethe, Ioannis Kottakis, Peter D'Andrea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3392; DOI: 10.1183/13993003.congress-2021.PA3392
Efficacy of different dosing regimens of azithromycin in a real-world severe asthma cohort
Ayesha Kumar, Seher Zaidi, Nicola Fay, Thomas Fitzmaurice, Abigail Watkin, Hannah Joplin, Hassan Burhan

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3526; DOI: 10.1183/13993003.congress-2021.PA3526
Mometasone/indacaterol (MF/IND) and mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) and FLU/SAL+tiotropium (TIO) in patients with inadequately controlled asthma: data from the PLATINUM program
Richard Van Zyl-Smit, Kenneth Chapman, Huib Kerstjens, Christian Gessner, Hironori Sagara, Ana-Maria Tanase, Motoi Hosoe, Xu Shu, Abhijit Pethe, David Lawrence, Hanns-Christian Tillmann, Karen Mezzi, Peter D’Andrea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3385; DOI: 10.1183/13993003.congress-2021.PA3385
The effects of nebulised beta-2 agonists on clinical observations in asthma exacerbations: a systematic review
Craig Mortimer, Dimitra Nikoletou, Ann Ooms, Julia Williams

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3533; DOI: 10.1183/13993003.congress-2021.PA3533
Inhaled antibiotic therapy in patients with severe asthma
ELENA AVALOS PEREZ-URRIA, Rosa María Girón Moreno, Carolina Victoria Cisneros Serrano, Elisa Martínez Besteiro, Marta Erro Iribarren, Adrián Martínez Vergara, Elena García Castillo, Ana Martínez Meca, Julio Ancochea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3534; DOI: 10.1183/13993003.congress-2021.PA3534

Main menu

User menu

Search

More articles from Airway pharmacology and treatment

Pages

Contact us